ActualSignal is on a mission to change Neurological disorders with innovative technology and a unique business approach, enhancing patient outcomes and leveraging healthcare incentives for financial gain. The company focuses on the way Parkinson's care is delivered, harnessing AI to generate personal disease profile and enabling continuous and better care with superior clinical outcomes. ActualSignal conducted three US clinical trials, and gained recognition from healthcare leaders.